GeneDx Stock (NASDAQ:WGS)
Previous Close
$86.48
52W Range
$32.21 - $170.87
50D Avg
$73.72
200D Avg
$84.37
Market Cap
$2.50B
Avg Vol (3M)
$753.51K
Beta
2.01
Div Yield
-
WGS Company Profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
WGS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 25 | Dec 24 | Dec 22 |
|---|---|---|---|
| Diagnostic Test | $416.67M | $302.16M | $227.33M |
| Diagnostic Test, Institutional Customers | $70.07M | $65.11M | - |
| Diagnostic Test, Self Pay | $1.36M | $2.34M | - |
| Diagnostic Test, Third Party Insurance | $345.24M | $234.70M | - |
| Product and Service, Other | $10.87M | $3.29M | $7.36M |
Latest
Fiscal year ends in Dec 25 | Currency in USD